Expanded access programs are pathways for patients with serious or life-threatening diseases to access drugs in development outside of clinical trials when there are no other treatment options available. These programs are also known by other names, such as Compassionate Use, Early Access Programs, Managed Access Programs and Named Patient Programs. They are primarily driven by physicians on behalf of their patients.
Madeleine Pagel
14 Aug 2026
14 mins read
Andrea Enguita
3 Aug 2026
18 mins read
Adrianne Rivard
14 Jul 2026
8 mins read
Theo Cantero
29 Jun 2026
10 mins read
myTomorrows Team
26 May 2026
4 mins read
Dennis Akkaya
26 May 2026
8 mins read
Andrea Enguita
20 May 2026
13 mins read
Andrea Enguita
19 May 2026
37 mins read
Andrea Enguita
20 Apr 2026
12 mins read
myTomorrows Team
16 Apr 2026
4 mins read